Drugmakers warn Greek medicine supply "may be in jeopardy" - (CNBC via NewsPoints Desk)

  • The European Federation of Pharmaceutical Industries and Associations (EFPIA) suggested that drug supply to Greece could be curtailed in the face of mounting unpaid bills by the country, as reported CNBC Monday.
  • "In the worst-case scenario of 'Grexit', we believe the integrity of the medicines supply chain may be in jeopardy, which would create a risk to public health," the organisation stated.
  • Although drugmakers reached an agreement to continue supplying drugs to the country, shortages could occur if steps are not taken to prevent the diversion of supplies to other countries.
  • EFPIA director general Richard Bergstrom said that drugmakers including Novartis, Pfizer, Roche and Sanofi wanted to continue supplying drugs to the country but that assistance from the European Commission is needed.
  • Drugmakers also argued that parallel drug trade, which is permitted under European free trade rules, should be temporarily restricted to prevent drug shortages in Greece.
  • According to a recent report, drugmakers are owed more than 1.1 billion euros by Greek hospitals and the state-run health insurer EOPYY after not being paid since December.

To read more NewsPoints articles, click here.